Calliditas Therapeutics AB (publ) CALT
40.00 +40.00
Quote time unavailable
Day range unavailable
52-week range unavailable
News
defenseworld.net Financial Survey: MindWalk (NASDAQ:HYFT) and Calliditas Therapeutics AB (publ) (NASDAQ:CALT) MindWalk (NASDAQ: HYFT - Get Free Report) and Calliditas Therapeutics AB (publ) (NASDAQ: CALT - Get Free Report) are both small-cap manufacturing companies, but which is the better stock? We will…
defenseworld.net Analyzing Cyclacel Pharmaceuticals (NASDAQ:BGMS) and Calliditas Therapeutics AB (publ) (NASDAQ:CALT) Calliditas Therapeutics AB (publ) (NASDAQ: CALT - Get Free Report) and Cyclacel Pharmaceuticals (NASDAQ: BGMS - Get Free Report) are both small-cap medical companies, but which is the superior…
defenseworld.net Calliditas Therapeutics AB (publ) (NASDAQ:CALT) & Palatin Technologies (PINK:PTNT) Critical Analysis Calliditas Therapeutics AB (publ) (NASDAQ: CALT - Get Free Report) and Palatin Technologies (PINK: PTNT - Get Free Report) are both small-cap medical companies, but which is the superior investment?…
defenseworld.net Head-To-Head Review: AngioSoma (OTCMKTS:SOAN) & Calliditas Therapeutics AB (publ) (NASDAQ:CALT) Risk and Volatility Calliditas Therapeutics AB (publ) has a beta of 1.77, indicating that its stock price is 77% more volatile than the S&P 500. Comparatively, AngioSoma has a beta of -0.46,…
defenseworld.net Evofem Biosciences (NASDAQ:EVFM) & Calliditas Therapeutics AB (publ) (NASDAQ:CALT) Head-To-Head Survey Profitability This table compares Evofem Biosciences and Calliditas Therapeutics AB (publ)'s net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets Evofem…
prnewswire.com Delisting of Calliditas Therapeutics AB (publ) from Nasdaq Stockholm STOCKHOLM , Sept. 16, 2024 /PRNewswire/ -- Nasdaq Stockholm has decided that Calliditas Therapeutics AB (publ) will be delisted from Nasdaq Stockholm.
prnewswire.com Notice of extraordinary meeting of Calliditas Therapeutics AB (publ) STOCKHOLM , Sept. 3, 2024 /PRNewswire/ -- The shareholders of Calliditas Therapeutics AB (publ) ("Calliditas Therapeutics"), Reg.
prnewswire.com Calliditas Therapeutics takes certain corporate actions following announcement by Asahi Kasei STOCKHOLM , Sept. 3, 2024 /PRNewswire/ -- Following the announcement by Asahi Kasei Corporation ("Asahi Kasei") on September 2, 2024 that it controls more than 90 percent of the outstanding shares of…
seekingalpha.com Calliditas Therapeutics AB (publ) (CALT) Q2 2024 Earnings Call Transcript Calliditas Therapeutics AB (publ) (NASDAQ:CALT ) Q2 2024 Earnings Conference Call August 13, 2024 8:30 AM ET Company Participants Renée Aguiar-Lucander - CEO Richard Philipson - CMO Maria Tornsen -…
prnewswire.com Calliditas Interim Report January to June 2024 STOCKHOLM , Aug. 13, 2024 /PRNewswire/ -- Calliditas Therapeutics AB (NASDAQ: CALT) (STO: CALTX) : April to June 2024 (compared to April to June 2023) Net sales amounted to SEK 559.8 million, of…
prnewswire.com Number of shares and votes in Calliditas Therapeutics STOCKHOLM , July 31, 2024 /PRNewswire/ -- During July, the number of shares and votes in Calliditas Therapeutics AB (publ) has changed due to the exercise of warrants under the company's long-term…
accesswire.com SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ATRI, CALT on Behalf of Shareholders NEW YORK, NY / ACCESSWIRE / July 28, 2024 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or…
globenewswire.com STOCKHOLDER ALERT: The M&A Class Action Firm Is Investigating the Merger and its Tender Offer for Calliditas Therapeutics AB – CALT NEW YORK, July 27, 2024 (GLOBE NEWSWIRE) -- NEW YORK, July 27, 2024 / GlobeNewswire/-- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized…
prnewswire.com STOCKHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of the Merger and its Tender Offer, Expiring August 30, 2024, for shares of Calliditas Therapeutics AB - CALT NEW YORK , July 26, 2024 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS…
prnewswire.com Calliditas announces positive TRANSFORM Phase 2b topline data in primary biliary cholangitis STOCKHOLM , July 26, 2024 /PRNewswire/ -- Calliditas Therapeutics AB (NASDAQ: CALT) (STOCKHOLM: CALTX) ("Calliditas") today announced that the Phase 2b TRANSFORM trial met its primary endpoint,…
prnewswire.com Launch of Phase 3 clinical trial with Nefecon in Japan STOCKHOLM , July 4, 2024 /PRNewswire/ -- Calliditas Therapeutics AB (NASDAQ: CALT) (STO: CALTX) ("Calliditas") today announces that its partner Viatris Pharmaceutical Japan G.K. ("Viatris") has…
prnewswire.com Calliditas provides setanaxib patent update STOCKHOLM , June 18, 2024 /PRNewswire/ -- Calliditas Therapeutics AB (Nasdaq: CALT) (Nasdaq Stockholm: CALTX) ("Calliditas") today announced that the United States Patent and Trademark Office (USPTO)…
prnewswire.com Bulletin from the annual general meeting of Calliditas Therapeutics AB (publ) STOCKHOLM , June 17, 2024 /PRNewswire/ -- The following resolutions were passed at Calliditas Therapeutics AB (publ) ("Calliditas") annual general meeting held today, on 17 June 2024, in Stockholm.…
accesswire.com SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AKLI, CALT on Behalf of Shareholders NEW YORK, NY / ACCESSWIRE / June 6, 2024 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or…
accesswire.com STOCKHOLDER ALERT: The M&A Class Action Firm Investigates Merger and Expiring Tender Offer - AKLI and CALT NEW YORK, NY / ACCESSWIRE / June 6, 2024 / Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS…
benzinga.com Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session 
benzinga.com Why Bank Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session Gainers Provention Bio, Inc. (NASDAQ: PRVB) shares jumped 250.8% to $23.50 after Sanofi announced it will acquire the company for $25 per share in cash.
benzinga.com Illumina, Seagen And Other Big Stocks Moving Higher On Monday U.S. stocks traded slightly lower, with the Nasdaq Composite dropping around 0.2% on Monday. Here are some big stocks recording gains in today’s session.
benzinga.com Earnings Scheduled For February 23, 2023 Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnings for its fourth quarter.- benzinga.com Earnings Scheduled For August 18, 2022 Companies Reporting Before The Bell • Calliditas Therapeutics (NASDAQ:CALT) is expected to report quarterly loss at $1.00 per share on revenue of $7.50 million.
benzinga.com Stocks That Hit 52-Week Highs On Monday During Monday's morning session, 460 companies made new 52-week highs.- benzinga.com Earnings Scheduled For August 13, 2020 Companies Reporting Before The Bell • Tapestry Inc. (NYSE:TPR) is estimated to report quarterly loss at $0.57 per share on revenue of $662.44 million.
benzinga.com Stocks That Hit 52-Week Highs On Wednesday During Wednesday's morning session, 145 stocks hit new 52-week highs.